Canada can be a leader in delivering widespread, well-regulated psychedelic-assisted therapy for people with depression, anxiety, post-traumatic stress disorder and substance abuse, by investing in research, educating health care professionals and providing the necessary clinical infrastructure, Dr. Ross Marshall, chief scientific officer at The Newly Institute based in Calgary, says in an op-ed.
Organization: The Newly Institute
New clinical approaches, research and funding needed to treat early traumas driving mental illness
More investment and research is needed to effectively treat the traumas that underlie mental illness and enable people to quickly get back to work and back to life, Dr. Robert Tanguay, vice-president and chief medical officer at The Newly Institute based in Calgary, says in an op-ed.